The Chinese market for herbal medicine is expected to grow to US $160 billion by 2020. While a lot of money has been expended on investigating traditional medicines, the scientific evidence to understand the active components of these remedies remains a mystery, something which is going to change with ChemoPower’s technology.
Above video is IP ValueLab’s interview with DR. George Zhang, CEO and Founder of ChemoPower Technology.